Keyt Bruce 4
4 · IGM Biosciences, Inc. · Filed Mar 5, 2024
Insider Transaction Report
Form 4
Keyt Bruce
Chief Scientific Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2024-03-01−3,026→ 0 total(indirect: See footnote)Exercise: $0.93Exp: 2024-03-05→ Common Stock (3,026 underlying) - Exercise/Conversion
Common Stock
2024-03-01$0.93/sh+3,026$2,814→ 4,039 total(indirect: See footnote)
Holdings
- 129,551
Common Stock
Footnotes (2)
- [F1]The securities are held directly by the reporting person's spouse.
- [F2]The shares subject to the option are vested and exercisable as of the date hereof.